11.67
price down icon2.18%   -0.26
after-market Dopo l'orario di chiusura: 11.68 0.010 +0.09%
loading

Greenwich Lifesciences Inc Azioni (GLSI) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
23.26%
4.046
3.2823 8.0842 2.7291 2.6614
Operating Income/Loss
23.26%
-4.046
-3.2823 -8.0842 -2.7291 -2.6614
Income/Loss From Continuing Operations Before Tax
23.54%
-4.0253
-3.2584 -8.0402 -2.6687 -2.6067
Income/Loss From Continuing Operations After Tax
23.54%
-4.0253
-3.2584 -8.0402 -2.6687 -2.6067
Net Income/Loss
23.54%
-4.0253
-3.2584 -8.0402 -2.6687 -2.6067
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.51%
13.37
13.17 0.0445 13.14 12.91
Diluted Average Shares
1.51%
13.37
13.17 0.0445 13.14 12.91
Basic Earnings Per Share
20.00%
-0.30
-0.25 -0.61 -0.20 -0.20
Diluted Earnings Per Share
20.00%
-0.30
-0.25 -0.61 -0.20 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Capitalizzazione:     |  Volume (24 ore):